Dances with black widow spiders: Dysregulation of glutamate signalling enters centre stage in ADHD

  title={Dances with black widow spiders: Dysregulation of glutamate signalling enters centre stage in ADHD},
  author={Klaus-Peter Lesch and S{\"o}ren Merker and Andreas Reif and M. Nov{\'a}k},
  journal={European Neuropsychopharmacology},

Figures from this paper

Glutamatergic candidate genes in autism spectrum disorder: an overview

It is concluded that glutamatergic genetic risk factors for ASD show a complex pattern and further studies are needed to fully understand its mechanisms, before translation of findings into clinical applications and individualized treatment approaches will be possible.

Emerging Evidence for the Widespread Role of Glutamatergic Dysfunction in Neuropsychiatric Diseases

A conceptual overview of brain glutamatergic activity and peripheral interfacing is presented, including the common mechanisms that diverse diseases share when glutamate homeostasis is disrupted.

Why is methylphenidate effective in ADHD

The increment of glycine levels improves NMDAR functions, resulting in improvement of ADHD, according to the following hypothesis.

Annual research review: The (epi)genetics of neurodevelopmental disorders in the era of whole-genome sequencing--unveiling the dark matter.

A backbone continuum concept of NDDs is discussed by summarizing pertinent findings in genetics and epigenetics and an appraisal of the genetic overlap versus differences is provided, with a focus on genome-wide screening approaches for (epi)genetic variation.

The effects of GRIN2B and DRD4 gene variants on local functional connectivity in attention-deficit/hyperactivity disorder

Results suggest that alterations in the glutamate and dopamine system in ADHD may contribute to abnormalities in local functional connectivity and its dynamic repertoire in the superior parietal area, and these abnormalities would be related to dysfunction in sustained and divided attention.

Early-life stress impairs developmental programming in Cadherin 13 (CDH13)-deficient mice

  • D. KiserS. Popp O. Rivero
  • Biology, Psychology
    Progress in Neuro-Psychopharmacology and Biological Psychiatry
  • 2019

MAP1B and NOS1 genes are associated with working memory in youths with attention-deficit/hyperactivity disorder

The findings suggest possible roles of NOS1 and MAP1B genes in WM performance in ADHD patients, replicating previous results with Nos1 gene in this cognitive domain in ADHD children.

Hippocampal overexpression of NOS1AP promotes endophenotypes related to mental disorders

The data provide a mechanistic explanation for a highly selective and specific contribution of hippocampal NOS1AP and its interaction with the glutamatergic postsynaptic density to cross-disorder pathophysiology and allude to therapeutic relevance due to the druggability of this molecule.

Glutamatergic copy number variants and their role in attention‐deficit/hyperactivity disorder

A role for glutamate in ADHD is suggested as CNVs in the glutamatergic genes investigated herein were associated with cognitive and clinical characteristics of ADHD individuals.



The ADHD-susceptibility gene lphn3.1 modulates dopaminergic neuron formation and locomotor activity during zebrafish development

Together, the results implicate decreased Lphn3 activity in eliciting ADHD-like behavior, and demonstrate its correlated contribution to the development of the brain dopaminergic circuitry.

Association of the glutamate receptor subunit gene GRIN2B with attention‐deficit/hyperactivity disorder

The data suggest an association between variations in the GRIN2B subunit gene and ADHD as measured categorically or as a quantitatively distributed trait.

Shank3 mutant mice display autistic-like behaviours and striatal dysfunction

It is shown that mice with Shank3 gene deletions exhibit self-injurious repetitive grooming and deficits in social interaction and a critical role for SHANK3 in the normal development of neuronal connectivity is demonstrated.

The genomic organisation of the metabotropic glutamate receptor subtype 5 gene, and its association with schizophrenia

The intron/exon structure of GRM5 was determined and a novel intragenic microsatellite was identified, suggestive of involvement of the GRM 5 gene in schizophrenia in this population of schizophrenics.

Attention-Deficit/Hyperactivity Phenotype in Mice Lacking the Cyclin-Dependent Kinase 5 Cofactor p35

A lifetime of attention-deficit/hyperactivity disorder: diagnostic challenges, treatment and neurobiological mechanisms

Converging evidence from clinical and genetic studies are presented arguing for a remarkable perseverance of ADHD-related symptomatology, taking into account the disorder’s variable and changing phenotype moderated by a high rate of comorbidity throughout the lifecycle.

Etiologic Subtypes of Attention-Deficit/Hyperactivity Disorder: Brain Imaging, Molecular Genetic and Environmental Factors and the Dopamine Hypothesis

Critical issues about etiologic subtypes of ADHD that may involve dopamine are identified, methods that could be used to address these issues are discussed, and old and new theories that may direct research in this area in the future are reviewed.